Categories
Uncategorized

Do like developing drugs for the treatment of CNS diseases?

We, from a life science company located in France, are looking for investors to improve and accelerate their R&D; but also for partners to share experience in Drug discovery with experience in Drug delivery.

Their focus is in developing drugs for the treatment of CNS diseases, their technology allows the selective vectorisation of drugs to the CNS without noxious side-effects outside the brain

Bitte kontaktieren Sie uns für weitere Details.

Leave a Reply

Your email address will not be published. Required fields are marked *